|Adverse effects of fullerenes on endothelial cells: fullerenol C60(OH)24 induced tissue factor and ICAM-I membrane expression and apoptosis in vitro.|
|Jump to Full Text|
|PMID: 18488416 Owner: NLM Status: MEDLINE|
|We studied the effects of a C60 water suspension at 4 microg/mL (nC60) and the water soluble fullerenol C60(OH)24 at final concentrations of 1-100 microg/mL on human umbilical vein endothelial cells (HUVECs) in culture. We found that a 24 hr treatment of HUVECs with C60(OH)24 at 100 microg/mL significantly increased cell surface expression of ICAM-1(CD54) (67 +/- 4% CD54+ cells vs. 19 +/- 2 % CD540 cells in control; p < 0.001). In addition, this treatment induced the expression of tissue factor (CD142) on HUVECs (54 +/- 20% CD142+ cells vs 4 +/- 2% CD142+ cells in control; p = 0.008) and increased exposure of phosphatidylserine (PS) (29 +/- 2% PS+ cells vs. 12 +/- 5% PS+ cells in control; p < 0.001). Analysis of cell cycle and DNA fragmentation (TUNEL) showed that both nC60 and C60(OH)24 caused G1 arrest of HUVECs and C60(OH)24 induced significant apoptosis (21 +/- 2% TUNEL+ cells at 100 microg/mL of C60(OH)24 vs. 4 +/- 2% TUNEL+ cells in control; p < 0.001). We also demonstrated that both nC60 and C60(OH)24 induced a rapid concentration dependent elevation of intracellular calcium [Ca2+]i. This could be inhibited by EGTA, suggesting that the source of [Ca2+]i in fullerene stimulated calcium flux is predominantly from the extracellular environment. In conclusion, fullerenol C60(OH)24 had both pro-inflammatory and pro-apoptotic effects on HUVECs, indicating possible adverse effects of fullerenes on the endothelium.|
|Monique P Gelderman; Olga Simakova; Jeffrey D Clogston; Anil K Patri; Sheena F Siddiqui; Alexander C Vostal; Jan Simak|
Related Documents :
|2161826 - Characterization of an in vitro system of human renal papillary collecting duct cells.
8006766 - Microencapsulation of lactococcus lactis subsp. cremoris.
12426166 - Effect of simvastatin on the proliferation of rat cardiac fibroblasts.
42366 - Study of the effects of neurotransmitters on the hypothalamus-pituitary-testis function...
1402126 - Variation in heat sensitivity through the cell cycle of m10 and burkitt p3hr-1 cells.
21663596 - Nano-biolistics: a method of biolistic transfection of cells and tissues using a gene g...
|Type: Journal Article; Research Support, N.I.H., Extramural|
|Title: International journal of nanomedicine Volume: 3 ISSN: 1176-9114 ISO Abbreviation: - Publication Date: 2008|
|Created Date: 2008-05-19 Completed Date: 2008-06-19 Revised Date: 2009-11-18|
Medline Journal Info:
|Nlm Unique ID: 101263847 Medline TA: Int J Nanomedicine Country: New Zealand|
|Languages: eng Pagination: 59-68 Citation Subset: IM|
|CBER, FDA, 1401 Rockville Pike, HFM 335, Rockville, MD 20852-1448, USA.|
|APA/MLA Format Download EndNote Download BibTex|
Cell Membrane / drug effects, metabolism
Cell Survival / drug effects
Dose-Response Relationship, Drug
Endothelial Cells / cytology, drug effects*, metabolism*
Fullerenes / adverse effects*
Gene Expression / drug effects
Intercellular Adhesion Molecule-1 / metabolism*
Thromboplastin / metabolism*
|N01-CO-12400/CO/NCI NIH HHS|
|0/Fullerenes; 126547-89-5/Intercellular Adhesion Molecule-1; 182024-42-6/fullerenol; 9035-58-9/Thromboplastin|
Journal ID (nlm-ta): Int J Nanomedicine
Journal ID (publisher-id): International Journal of Nanomedicine
Publisher: Dove Medical Press
? 2008 Dove Medical Press Limited. All rights reserved
Print publication date: Month: 3 Year: 2008
Electronic publication date: Month: 3 Year: 2008
Volume: 3 Issue: 1
First Page: 59 Last Page: 68
PubMed Id: 18488416
|Adverse effects of fullerenes on endothelial cells: Fullerenol C60(OH)24 induced tissue factor and ICAM-1 membrane expression and apoptosis in vitro|
|Monique P Gelderman1|
|Jeffrey D Clogston3|
|Anil K Patri3|
|Sheena F Siddiqui1|
|Alexander C Vostal1|
1CBER, FDARockville, MD USA
2School of Medicine, USUHSBethesda, MD, USA
3Nanotechnology Characterization Lab, Advanced Technology ProgramSAIC-Frederick, Frederick, Maryland, USA
|Correspondence: Correspondence: Jan Simak CBER, FDA, 1401 Rockville Pike, HFM 335, Rockville, MD 20852-1448 Tel +1 301 827 3978 Fax +1 301 402 2780 Email email@example.com
Carbon fullerenes have enormous practical potential in the field of biomedical nano-technology. Fullerenes and carbon nanotubes have already had a profound impact on the development of diagnostic biosensors, drug delivery nanosystems, and imaging nanoprobes for intravascular use. In addition, fullerenes can be used as components in a variety of plastics, including filtration membranes (Bosi et al 2003; Endo et al 2004; Bianco et al 2005; Sinha and Yeow 2005; Djordjevic et al 2006; Lacerda et al 2006; Polizu et al 2006; Harrison and Atala 2007). It has been reported that hydroxylated fullerene derivatives have potent antioxidant properties (Dugan et al 1996; Tsai et al 1997; Huang et al 1998; Straface et al 1999; Wang et al 1999; Jin et al 2000). Furthermore, the cytoprotective effects of fullerene derivatives in oxidative stress, mostly by free radical scavenging, have been demonstrated in different cell lines in vitro, and also on animal models, in vivo (Lin et al 1999; Tsao et al 1999; Lai et al 2000; Gharbi et al 2005; Daroczi et al 2006). It has been shown that fullerene derivatives have anti-viral and anti-bacterial properties. Also, their photodynamic cytotoxicity has been employed in experimental anti-tumor therapy and pathogen inactivation (Kasermann and Kempf 1997; Tabata et al 1997). However, several studies are raising safety concerns by showing possible cytotoxic effects of fullerenes and their derivatives (Sera et al 1996; Chen et al 1998; Kamat et al 1998; Wolff et al 2000; Oberdorster 2004; Sayes et al 2005; Isakovic et al 2006; Zhu et al 2006). Although, it has been demonstrated that residual tetrahydrofuran (THF) used for the C60 fullerene solubilization substantially potentiates the toxicity of C60, the recent studies using the THF free water suspensions of fullerenes or water soluble polyhydroxylated fullerenols indicate their cytotoxic effects (Isakovic et al 2006; Zhu et al 2006). Despite the fact that many of the fullerene applications are based on intravascular administration of these compounds, very little is known about the effects of fullerenes on endothelial cells (Yamawaki and Iwai 2006). Here we present a study investigating pro-apoptotic and pro-inflammatory effects of water soluble fullerenol C60(OH)24 and a C60 fullerene water suspension (nC60) on cultured human umbilical vein endothelial cells.
The water soluble poly-hydroxylated fullerene derivative fullerenol C60(OH)24 (at final concentrations of 1?100 ?g/mL) from MER Corp., Tuscon, AZ was used for all experiments. In addition, the water nanocrystalline suspensions of insoluble C60 (nC60) (C60 of 99.5% purity from SES Res., Houston, TX, USA) was prepared by continuous stirring 400 mg of C60 powder in 400 mL of Milli-Q water for 2 weeks at room temperature. After stirring, the suspension was centrifuged twice at 4000 g for 20 minutes to remove larger aggregates of undissolved fullerene. The final supernatant which contained 21 ?g/mL of nC60 was collected, and stored at 4 ?C. The concentration of nC60 was determined by extracting the C60 from the suspension by toluene and analyzing the absorbance at 336 nm, as described by Lyon et al (2006). In tissue culture experiments, the supernatant was diluted with the culture medium to a final concentration of 4 ?g/mL. As a control, the fullerene vehicle (Millli-Q H2O) was prepared in parallel by continuous stirring for 2 weeks at room temperature and manipulated the same way as nC60 suspension.
The Malvern Zetasizer Nano ZS instrument (Southborough, MA) with a back scattering detector was used for measuring the hydrodynamic size (diameter) in batch mode (no fractionation) at 25 ?C in a low volume quartz cuvette. The relative particle volume is used as the size class for histograms of the size distribution (the diameter is plotted on the abscissa and the particle volume on the ordinate). The average diameter (weighted by particle volume) of the largest peak in the volume distribution is reported as the hydrodynamic size, along with its standard deviation and the percentage of the total volume contained in the largest peak. The nC60 sample concentration was 21 ?g/mL as described in the stock preparation (see above). The hydroxylated C60 derivative (C60(OH)24) was weighed and dissolved in 10 mM NaCl to give a final concentration of 2 mg/mL and filtered through a 0.02?m filter (Anotop 10 Plus, Whatman International Ltd., Maidstone, England). A minimum of twelve measurements were made per sample.
HUVECs (2nd passage) from Cambrex (Walkersville, MD), were cultured in either 6 or 24 well plates (Becton Dickinson Labware, Franklin Lakes, NJ) with EGM-2 media containing 2% fetal bovine serum and supplements (Cambrex). Cells were used for experiments when they reached 80%?90% confluence (~48 hrs in culture). HUVECs were washed and incubated for 24 hrs at 37 ?C with fullerenol C60(OH)24 or fullerene nC60 in water diluted one to five with the EGM-2 medium. After incubation, cells were harvested with 20 mM HEPES buffer with 100 mM NaCl, 0.5% BSA and 10 mM EDTA, pH 7.4. After harvesting, the cells were centrifuged (300 g for 5 min), washed with Hanks? balanced salt solution with 0.35% bovine serum albumin (HBSS/BSA) and used for analysis.
Cy-Chrome conjugated anti-human monoclonal antibody (mAb) to CD54 (ICAM-1, clone HA58), phycoerythrin-conjugated (PE) anti-human mAb to CD142 (tissue factor, clone HTF-1), isotype matched controls, annexin V (FITC-conjugated), and an APO-BRDU kit were purchased from BD Pharmingen (San Diego, CA). All antibodies were titrated to ensure saturating concentrations.
Approximately 105 cells were resuspended in 50 ?L of HBSS/BSA and incubated with saturating concentration of the mAbs or annexin V. Non-labeled cells and cells incubated with either relevant isotype controls or with annexin V in the presence of 20 mM EDTA were prepared as controls. After 20 min incubation at room temperature, the suspension of labeled cells was diluted with 2 mL of HBSS/BSA and centrifuged (300 ? g for 5 min). Sedimented cells were resuspended in 0.5 mL of HBSS/BSA and analyzed using flow cytometry.
Cell samples were analyzed as described previously (Simak et al 2002; Simak, Holada, and Vostal et al 2002). Briefly, a FACSCalibur flow cytometer (Becton Dickinson, San Diego, CA, USA) equipped with CELLQuest software, with forward scatter (FSC) and side scatter (SSC) in linear mode was used. Populations of intact cells were gated according to their light-scattering characteristics in order to exclude debris, and 10,000 gated cells were analyzed for each sample. The total percentage (%) of CD54+, CD142+, and PS+ (annexin V-binding) cells was evaluated. Apoptosis (TUNEL) was analyzed using the APO-BRDU kit following the manufacturer?s instructions (BD Pharmingen, San Diego, CA). In addition, cell cycle analysis was performed using ModFit software (Verity Software House, Topsham, ME).
The acute effect of fullerenes on intracellular free Ca2+ concentration was studied in HUVEC loaded with a Ca2+- sensitive probe (FURA-2AM). Changes in fluorescence in individual cells (n = 100) were monitored at 340 nm and 380 nm excitation (the rate of data capture was 170/min) using a Nikon inverted epi-fluorescence/phase microscope equipped with a low-light level integrating CCD camera with a microphotometer assembly (InCyt I/P-2 TM Imaging and Photometry System, Intracellular Imaging Inc., Cincinnati, OH). Intracellular [Ca2+]i in real time was calculated from the ratio of emission detected at 510 nm at two excitation wavelengths (340 nm and 380 nm) and by comparison to a standard curve established for these settings using buffers of known free [Ca2+] with the InCyt Im2 software.
Results are presented as means ? standard deviations (SD). Kruskal-Wallis One Way Analysis of Variance on Ranks and multiple comparisons using Student-Newman-Keuls method or Dunett?s method was used where appropriate (SPSS 12; SPSS, Chicago, IL). A value of p < 0.05 was considered statistically significant.
The mean size distribution by volume and the mean hydrodynamic diameter of nC60 and C60(OH)24 are shown in Figure 1. Based on the size distributions of particles present in the nC60 water suspension (Figure 1A), the major water soluble component is about 224 nm in size. The small peak at about 5000 nm corresponds to approximately 2% of the total particle volume, and may be due to aggregates. Since unmodified nC60 is not immediately water soluble, we stirred C60 in water for two weeks, which resulted in a nanocrystalline suspension of stable aggregates (nC60). nC60 refers to an unknown number ?n? of C60 molecules agglomerating to form the suspension. The formed clusters contain unmodified C60 in their centers, surrounded by partially hydroxylated C60 on the outside (Fortner et al 2005). In contrast, the fullerenol C60(OH)24 is very soluble in water. Based on its size distribution by volume (Figure 1B), only one peak at 4.3 nm was observed, as expected for the hydroxylated C60 derivative.
HUVECs were cultured for 24 hrs with different concentrations of fullerenol C60(OH)24, (1, 10, 50, and 100 ?g/mL), fullerene nC60 at 4 ?g/mL, or with the vehicle. Flow cytometry was used to analyze the difference in expression of several surface markers. Figure 2 shows that the 24 hr treatment of HUVECs with 100 ?g/mL C60(OH)24 significantly increased cell surface expression of ICAM-1(CD54) (67 ? 4% CD54+ cells vs 19 ? 2% CD54+ cells in control; p < 0.001). This treatment also induced expression of tissue factor (CD142) on HUVECs (54 ? 20% CD142+ cells vs 4 ? 2% CD142+ cells in control; p = 0.008). In addition, an increase in exposed phosphatidylserine (PS, detected by Annexin V) (29 ? 2% PS+ cells vs 12 ? 5% PS+ cells in control; p < 0.001) was identified. However, treating the HUVECs with lower concentrations of fullerenol C60(OH)24 or nC60 at 4 ?g/mL did not induce a significant increase of surface expression of CD54, CD142 or PS.
Analysis of the cell cycle by flow cytometry showed that both nC60 at 4 ?g/mL and C60(OH)24 at concentrations 10 - 100 ?g/mL caused significant G1 arrest in HUVECs after 24 hours of treatment (Figure 3). In addition, fullerenol C60(OH)24 at 100 ?g/mL induced significant apoptosis after 24 hours treatment of HUVECs, as compared to control cells treated with the vehicle (21 ? 2% TUNEL+ cells at 100 ?g/mL of C60(OH)24 vs. 4 ? 2% TUNEL+ cells in control; p < 0.001) (Figure 4). Treating the HUVECs with lower concentrations of fullerenol C60(OH)24 or nC60 at 4 ?g/mL did not induce significant increase of TUNEL+ cells.
The acute effect of fullerenes on intracellular free Ca2+ concentration [Ca2+]i was studied, using a ratio fluorometry in HUVECs. Cells were loaded with a Ca2+-sensitive probe FURA-2AM. We demonstrated that both nC60 and C60(OH)24 induced a rapid concentration dependent elevation of [Ca2+]i. nC60 caused a continuous increase in [Ca2+]i and was about ten times more potent compared to C60(OH)24 (Figure 5). This activity of both C60(OH)24 and nC60 could be inhibited by EGTA, suggesting that the source of [Ca2+]i in fullerene stimulated calcium flux is predominantly from the extracellular environment.
Our study showed that fullerenol induced pro-inflammatory activation of cultured HUVECs, which was indicated by the increase of CD54 (ICAM-1) and CD142 (TF) surface expression. The intercellular adhesive molecule 1 (ICAM-1), also referred to as CD54, is an adhesive receptor of the immunoglobulin gene superfamily. It is constitutively expressed at low levels on most types of vascular endothelial cells, and is highly upregulated on pro-inflammatory cytokine activated endothelium (Mutin et al 1997a). Tissue factor (TF), also referred to as CD142, is a cellular receptor and cofactor of activated factor VIIa. Tissue factor initiates activation of the plasma coagulation system, which leads to the generation of thrombin activity (Steffel et al 2006). Although functional TF is not exposed in significant levels on resting HUVECs, its expression is greatly increased after stimulation with pro-inflammatory cytokines and some other stimuli, similarly to ICAM-1 (Mutin et al 1997b). In addition, the observed increased exposure of phosphatidylserine (PS) on the plasma membrane of HUVECs indicates a disturbance of the membrane asymmetry, likely due to pro-apoptotic stimulation or other types of cell activation. Although the exposure of PS on cells incubated with the fullerenol vehicle (the Milli-Q water) was higher than expected, the difference in PS-surface exposure between vehicle- treated and fullerenol-treated cells was highly significant (P < 0.001). PS is an essential cofactor for activation complexes in the plasma coagulation system. Also, it is a signaling molecule for phagocytes (Zwaal et al 2005). Thus, our results show that the phenotype of endothelial cells treated with fullerenol become pro-inflammatory and pro-coagulant. It is important to further investigate whether fullerenes exhibit similar effects on the endothelium in vivo in animal models.
Our cell cycle analysis showed that both nC60 and C60(OH)24 induced G1 arrest in HUVECs. Polyhydroxylated fullerenol-1 was reported to inhibit the proliferative responses in a variety of cells, including smooth muscle cells and human lymphocytes, in a concentration dependent manner. The tested concentration range was of 10-6 to 10-2 M, which corresponds to approximately 1 ?g/mL to 10 mg/mL. It was also shown that fullerenol inhibited cytosolic protein kinase C activity. Therefore, it was suggested that the anti-proliferative effect of fullerenol-1 on vascular smooth muscle cells may partly be mediated through the inhibition of protein tyrosine kinase (Lu et al 1998).
We found that C60(OH)24 induced apoptosis in HUVECs. This was clearly detected by TUNEL assay, which is a common method for detecting DNA fragmentation. In addition, the observed increase in PS exposure of fullerenol treated cells can be considered as supporting evidence of pro-apoptotic activation of HUVECs. Our finding contradicts the results of a recent study by Yamawaki and Iwai (Yamawaki and Iwai 2006). These authors concluded that fullerenol did not cause apoptosis based on the failure to demonstrate cleavage of caspase 3 and PARP. However, their study showed autophagic cell death in fullerenol treated HUVECs. We may therefore speculate that both apoptotic and autophagic cell death may occur in fullerenol treated endothelium.
To investigate a possible mechanism of fullerene action on endothelium, we demonstrated that both nC60 and C60(OH)24 induced influx of extracellular Ca2+ in HUVECs. This suggests that fullerenes may either activate some of the Ca2+ channels on the cell membrane, or that they may create new channels/pores to facilitate Ca2+ influx, or both. In either case, it results in an increase in intracellular Ca2+, which may induce activation and/or apoptotic changes of the cells.
In conclusion, the results of this pilot study show possible adverse effects of fullerenes on the endothelium. The hydroxyfullerene C60(OH)24, had both pro-inflammatory and pro-apoptotic effects on endothelial cells. In addition, cell cycle arrest and increase of intracellular Ca2+ was observed in cells treated with hydroxyfullerene C60(OH)24 and also with a low concentration of nC60. With the wide potential applications of fullerenes in mind, the safety hazards of these materials need to be thoroughly evaluated. We suggest that additional in depth studies should be performed to investigate possible adverse effects of fullerenes on the cardiovascular system in exposed populations.
fn2The findings and conclusions in this article have not been formally disseminated by the Food and Drug Administration and should not be construed to represent any Agency determination or policy.
This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.
|Bianco A,Kostarelos K,Prato M. Applications of carbon nanotubes in drug deliveryCurr Opin Chem Biol 2005;9:674–9. [pmid: 16233988]|
|Bosi S,Da Ros T,Spalluto G,et al. Fullerene derivatives: an attractive tool for biological applicationsEur J Med Chem 2003;38:913–23. [pmid: 14642323]|
|Chen HH,Yu C,Ueng TH,et al. Acute and subacute toxicity study of water-soluble polyalkylsulfonated C60 in ratsToxicol Pathol 1998;26:143–51. [pmid: 9502397]|
|Daroczi B,Kari G,McAleer MF,et al. In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish modelClin Cancer Res 2006;12:7086–91. [pmid: 17145832]|
|Djordjevic A,Bogdanovic G,Dobric S. Fullerenes in biomedicineJ Buon 2006;11:391–404. [pmid: 17309168]|
|Dugan LL,Gabrielsen JK,Yu SP,et al. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neuronsNeurobiol Dis 1996;3:129–35. [pmid: 9173920]|
|Endo M,Hayashi T,Kim YA,et al. Applications of carbon nanotubes in the twenty-first centuryPhilos Transact A Math Phys Eng Sci 2004;362:2223–38. [pmid: 15370479]|
|Fortner JD,Lyon DY,Sayes CM,et al. C60 in water: nanocrystal formation and microbial responseEnviron Sci Technol 2005;39:4307–16. [pmid: 15984814]|
|Gharbi N,Pressac M,Hadchouel M,et al. fullerene is a powerful antioxidant in vivo with no acute or subacute toxicityNano Lett 2005;5:2578–85. [pmid: 16351219]|
|Harrison BS,Atala A. Carbon nanotube applications for tissue engineeringBiomaterials 2007;28:344–53. [pmid: 16934866]|
|Huang YL,Shen CK,Luh TY,et al. Blockage of apoptotic signaling of transforming growth factor-beta in human hepatoma cells by carboxyfullereneEur J Biochem 1998;254:38–43. [pmid: 9652391]|
|Isakovic A,Markovic Z,Todorovic-Markovic B,et al. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullereneToxicol Sci 2006;91:173–83. [pmid: 16476688]|
|Jin H,Chen WQ,Tang XW,et al. Polyhydroxylated C(60), fullerenols, as glutamate receptor antagonists and neuroprotective agentsJ Neurosci Res 2000;62:600–7. [pmid: 11070504]|
|Kamat JP,Devasagayam TP,Priyadarsini KI,et al. Oxidative damage induced by the fullerene C60 on photosensitization in rat liver microsomesChem Biol Interact 1998;114:145–59. [pmid: 9839628]|
|Kasermann F,Kempf C. Photodynamic inactivation of enveloped viruses by buckminsterfullereneAntiviral Res 1997;34:65–70. [pmid: 9107386]|
|Lacerda L,Bianco A,Prato M,et al. Carbon nanotubes as nanomedicines: from toxicology to pharmacologyAdv Drug Deliv Rev 2006;58:1460–70. [pmid: 17113677]|
|Lai HS,Chen WJ,Chiang LY. Free radical scavenging activity of fullerenol on the ischemia-reperfusion intestine in dogsWorld J Surg 2000;24:450–4. [pmid: 10706918]|
|Lin AM,Chyi BY,Wang SD,et al. Carboxyfullerene prevents iron-induced oxidative stress in rat brainJ Neurochem 1999;72:1634–40. [pmid: 10098871]|
|Lu LH,Lee YT,Chen HW,et al. The possible mechanisms of the antiproliferative effect of fullerenol, polyhydroxylated C60, on vascular smooth muscle cellsBr J Pharmacol 1998;123:1097–102. [pmid: 9559892]|
|Lyon DY,Adams LK,Falkner JC,et al. Antibacterial activity of fullerene water suspensions: effects of preparation method and particle sizeEnviron Sci Technol 2006;40:4360–6. [pmid: 16903271]|
|Mutin M,Dignat-George F,Sampol J. Immunologic phenotype of cultured endothelial cells: quantitative analysis of cell surface moleculesTissue Antigens 1997a;50:449–58. [pmid: 9389318]|
|Mutin M,Dignat-George F,Sampol J. Immunologic phenotype of cultured endothelial cells: quantitative analysis of cell surface moleculesTissue Antigens 1997b;50:449–58. [pmid: 9389318]|
|Oberdorster E. Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bassEnviron Health Perspect 2004;112:1058–62. [pmid: 15238277]|
|Polizu S,Savadogo O,Poulin P,et al. Applications of carbon nanotubes-based biomaterials in biomedical nanotechnologyJ Nanosci Nanotechnol 2006;6:1883–904. [pmid: 17025102]|
|Sayes CM,Gobin AM,Ausman KD,et al. Nano-C60 cytotoxicity is due to lipid peroxidationBiomaterials 2005;26:7587–95. [pmid: 16005959]|
|Sera N,Tokiwa H,Miyata N. Mutagenicity of the fullerene C60-generated singlet oxygen dependent formation of lipid peroxidesCarcinogenesis 1996;17:2163–9. [pmid: 8895484]|
|Simak J,Holada K,D?Agnillo F,et al. Cellular prion protein is expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasmaTransfusion 2002;42:334–42. [pmid: 11961239]|
|Simak J,Holada K,Vostal JG. Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecinBMC Cell Biol 2002;3:11. [pmid: 12052248]|
|Sinha N,Yeow JT. Carbon nanotubes for biomedical applicationsIEEE Trans Nanobioscience 2005;4:180–95. [pmid: 16117026]|
|Steffel J,Luscher TF,Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implicationsCirculation 2006;113:722–31. [pmid: 16461845]|
|Straface E,Natalini B,Monti D,et al. C3-fullero-tris-methanodicarboxylic acid protects epithelial cells from radiation-induced anoikia by influencing cell adhesion abilityFEBS Lett 1999;454:335–40. [pmid: 10431834]|
|Tabata Y,Murakami Y,Ikada Y. Photodynamic effect of polyethylene glycol-modified fullerene on tumorJpn J Cancer Res 1997;88:1108–16. [pmid: 9439687]|
|Tsai MC,Chen YH,Chiang LY. Polyhydroxylated C60, fullerenol, a novel free-radical trapper, prevented hydrogen peroxide- and cumene hydroperoxide-elicited changes in rat hippocampus in-vitroJ Pharm Pharmacol 1997;49:438–45. [pmid: 9232545]|
|Tsao N,Kanakamma PP,Luh TY,et al. Inhibition of Escherichia coli-induced meningitis by carboxyfullerenceAntimicrob Agents Chemother 1999;43:2273–7. [pmid: 10471578]|
|Wang IC,Tai LA,Lee DD,et al. C(60) and water-soluble fullerene derivatives as antioxidants against radical-initiated lipid peroxidationJ Med Chem 1999;42:4614–20. [pmid: 10579823]|
|Wolff DJ,Papoiu AD,Mialkowski K,et al. Inhibition of nitric oxide synthase isoforms by tris-malonyl-C(60)-fullerene adductsArch Biochem Biophys 2000;378:216–23. [pmid: 10860539]|
|Yamawaki H,Iwai N. Cytotoxicity of water-soluble fullerene in vascular endothelial cellsAm J Physiol Cell Physiol 2006;290:C1495–502. [pmid: 16407415]|
|Zhu S,Oberdorster E,Haasch ML. Toxicity of an engineered nanoparticle (fullerene, C60) in two aquatic species, Daphnia and fathead minnowMar Environ Res 2006;62(Suppl):S5–9. [pmid: 16709433]|
|Zwaal RF,Comfurius P,Bevers EM. Surface exposure of phosphatidylserine in pathological cellsCell Mol Life Sci 2005;62:971–88. [pmid: 15761668]|
Keywords: endothelial cells, fullerenes, tissue factor, apoptosis, ICAM-1, flow cytometry.
Previous Document: The mitochondrial genome, a growing interest inside an organelle.
Next Document: Formation of potential titanium antigens based on protein binding to titanium dioxide nanoparticles.